1. Yang F, et al. Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements. Diabetes, metabolic syndrome and obesity: targets and therapy. 2015;8: 315.##
2. Hadi HA, Al Suwaidi J. Endothelial dysfunction in diabetes mellitus. Vascular health and risk management. 2007; 3(6):853. ##
3. Paneni F, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. European heart journal. 2013; 34(31): 2436-2443. ##
4. Endemann DH, Schiffrin EL. Endothelial dysfunction. Journal of the American Society of Nephrology. 2004;15(8): 1983-1992. ##
5. Yuyun MF, Ng LL, Ng GA. Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy? Microvascular research. 2018; 119: 7-12. ##
6. Tousoulis D, et al. The role of nitric oxide on endothelial function. Current vascular pharmacology. 2012; 10(1): 4-18. ##
7. Li Q, Yon JY, Cai H. Mechanisms and consequences of eNOS dysfunction in hypertension. Journal of hypertension. 2015; 33(6): 1128. ##
8. Palmer RM, Ferrige A, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987; 327(6122): 524-526. ##
9. Be³towski J, Kêdra A. Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy. Pharmacological Reports. 2006; 58(159): 159-178. ##
10. Jung CH, et al. Vaspin increases nitric oxide bioavailability through the reduction of asymmetric dimethylarginine in vascular endothelial cells. PLoS One. 2012; 7(12): e52346. ##
11. Hida K, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proceedings of the national academy of sciences. 2005; 102(30): 10610-10615. ##
12. Sun N, Wang H, Wang L. Vaspin alleviates dysfunction of endothelial progenitor cells induced by high glucose via PI3K/Akt/eNOS pathway. International journal of clinical and experimental pathology. 2015; 8(1): 482. ##
13. Perticone F, et al., Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. Journal of the American College of Cardiology. 2005; 46(3): 518-523. ##
14. Madaric, J., et al. Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia. Madaric et al. Stem Cell Research & Therapy. 2017; 8:165: 2-7. ##
15. El Assar M, et al., Asymmetric dimethylarginine (ADMA) elevation and arginase up‐regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans. The Journal of physiology. 2016; 594(11): 3045-3060. ##
16. Kielstein JT, et al., ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke. 2006; 37(8): 2024-2029. ##
17. Joyner MJ, Green DJ. Exercise protects the cardiovascular system: effects beyond traditional risk factors. The Journal of physiology. 2009; 587(23): 5551-5558. ##
18. Francois ME, Little JP. The impact of acute high-intensity interval exercise on biomarkers of cardiovascular health in type 2 diabetes. European journal of applied physiology. 2017; 117(8): 1607-1616. ##
19. Ghardashi Afousi A, et al. Improved brachial artery shear patterns and increased flow‐mediated dilatation after low‐volume high‐intensity interval training in type 2 diabetes. Experimental physiology. 2018;103(9):1264-1276. ##
20. Silva CAd, et al., Effect of high-intensity exercise on endothelial function in patients with t2dm. Revista Brasileira de Medicina do Esporte. 2016;22(2):126-130. ##
21. Mitranun W, et al. Continuous vs interval training on glycemic control and macro‐and microvascular reactivity in type 2 diabetic patients. Scandinavian journal of medicine & science in sports. 2014;24(2): e69-e76. ##
22. Tanahashi K, et al. Aerobic exercise training decreases plasma asymmetric dimethylarginine concentrations with increase in arterial compliance in postmenopausal women. American journal of hypertension. 2014;27(3): 415-421. ##
23. Seljeflot,I, et al. The L-arginine–asymmetric dimethylarginine ratio is strongly related to the severity of chronic heart failure. No effects of exercise training. Journal of cardiac failure. 2011;17(2):135-142. ##
24. Sculthorpe N, et al. Effects of subsequent high intensity interval training (HIIT) on l-arginine, dimethyarginines (adma; Sdma) and their ratios in ageing males. Medicine & Science in Sports & Exercise. 2014; 46(5):720-721. ##
25. Aktaş H, et al. The effects of high intensity-interval training on vaspin, adiponectin and leptin levels in women with polycystic ovary syndrome. Archives of Physiology and Biochemistry. 2019; 1-6. ##
26. Regensteiner JG, et al. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Medicine & Science in Sports & Exercise. 1995. ##
27. Wisloff U, et al. Superior Cardiovascular Effect Of Aerobic Interval-training Versus Moderate Continuous Training In Elderly Heart Failure Patients: 651May 31 8: 15 AM-8: 30 AM. Medicine & Science in Sports & Exercise. 2007;39(5):S32. ##
28. Izadi MR, et al. High-intensity interval training lowers blood pressure and improves apelin and NOx plasma levels in older treated hypertensive individuals. Journal of physiology and biochemistry. 2018; 74(1):47-55. ##
29. Tjønna A, Lee sJ, Rognmo Ø, stølen TO, bye A, Haram pM et al. Aerobic interval training vs continuous moderate exercise as a treatment for the metabolic syndrome. Circulation. 2008;118:346-354. ##
30. Seibaek M, et al. Insulin resistance and maximal oxygen uptake. Clinical Cardiology: An International Indexed and Peer‐Reviewed Journal for Advances in the Treatment of Cardiovascular Disease. 2003; 26(11):515-520. ##
31. Little JP, et al. Low-volume high-intensity interval training reduces hyperglycemia and increases muscle mitochondrial capacity in patients with type 2 diabetes. Journal of applied physiology. 2011; 111(6):1554-1560. ##
32. Kadoglou N, et al. The differential anti‐inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with type 2 diabetes. Diabetic Medicine. 2013; 30(2): e41-e50. ##
33. Hamasaki H. Interval exercise therapy for type 2 diabetes. Current diabetes reviews. 2018;14(2):129-137. ##
34. Wieczór R, Wieczór AM, Kulwas A, Rość D. ADMA (asymmetric dimethylarginine) and angiogenic potential in patients with type 2 diabetes and prediabetes. Experimental Biology and Medicine. 2020; 153537022095973. ##
35. Taşkıran B, et al. Effect of Exercise on ADMA Level in Type 2 Diabetes Mellitus. Balkan Medical Journal. 2012; 29(1). ##
36. Fiodorenko-Dumas Z, Dumas I, Mastej K, Adamiec R. Physical activity - related changes in ADMA and vWF levels in patients with type 2 diabetes: A preliminary study. Advances in Clinical and Experimental Medicine. 2017;26(4): 601-608##
37. Pawlak‐Chaouch M, et al. Plasma asymmetric dimethylarginine concentrations are not related to differences in maximal oxygen uptake in endurance trained and untrained men. Experimental physiology. 2019;104(2):254-263. ##
38. Sydow K, Münzel T. ADMA and oxidative stress. Atherosclerosis Supplements. 2003;4(4): 41-51. ##
39. Mogharnasia M, TaheriChadorneshinb H, Abbasi-Deloei N. Effect of exercise training type on plasma levels of vaspin, nesfatin-1, and high-sensitivity C-reactive protein in overweight and obese women. Obesity Medicine. 2019;13:34-38. ##
40. AsaadiV, Azizbeigi K, Khosravi N, Hagh Nazari N. Effect of Exercise Training on Omentin-1 and Vaspin: Comparison of Continuous Endurance, Circuit Resistance, and High Intensity Interval Trainings in Obese Young Men. Journal Rehabilitation Medicine. 2020; 8(4):103-112. ##
41. Jung CH, et al. Vaspin inhibits cytokine-induced nuclear factor-kappa B activation and adhesion molecule expression via AMP-activated protein kinase activation in vascular endothelial cells. Cardiovascular diabetology. 2014;13(1): 41. ##